Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Cash flows from operating activities:
Net income before attribution of non-controlling interests	$ 635,855	$ 310,703	$ 444,913
Adjustments to reconcile net income to net cash provided by operating activities:
Pretax restructuring charges and asset impairments charges	148,151	182,274	48,746
Restructuring payments	(107,002)	(119,565)	(105,090)
Special pension plan contributions	123,000	0	125,000
Proceeds (payments) for settlement of derivative instruments	0	31,774	(20,281)
Goodwill impairment	130,150
Gain (Loss) on Sale of Leverage Leases	(26,689)
Depreciation and amortization	272,142	303,653	338,895
Stock-based compensation	18,692	20,111	22,523
Deferred taxes	34,358	(34,387)	(10,947)
Changes in operating assets and liabilities, excluding effects of acquisitions:
(Increase) decrease in accounts receivable	58,951	43,204	84,182
(Increase) decrease in finance receivables	190,153	180,352	206,823
(Increase) decrease in inventories	(12,830)	(11,913)	12,187
(Increase) decrease in prepaid, deferred expense and other assets	(12,104)	(8,658)	(15,036)
Increase (decrease) in accounts payable and accrued liabilities	(12,871)	28,766	(127,256)
Increase (decrease) in current and non-current income taxes	(257,631)	5,217	79,615
Increase (decrease) in advance billings	(12,854)	11,430	(2,744)
Increase (decrease) in other operating capital, net	(3,278)	9,150	(7,462)
Net cash provided by operating activities	920,193	952,111	824,068
Cash flows from investing activities:
Short-term and other investments	(67,786)	(122,464)	(8,362)
Proceeds from the sale of facilities	683	12,595	0
Capital expenditures	(155,980)	(119,768)	(166,728)
Net investment in external financing	(2,677)	(4,718)	1,456
Acquisitions, net of cash acquired	0	(77,537)	0
Reserve account deposits	35,354	10,399	1,664
Proceeds from sale of other assets	101,784
Net cash used in investing activities	(88,622)	(301,493)	(171,970)
Cash flows from financing activities:
Decrease in notes payable, net	(50,000)	(170,794)	(389,666)
Proceeds from long-term obligations	0	0	297,513
Principal payments on long-term obligations	0	0	(150,000)
Proceeds from issuance of stock	12,934	11,423	11,962
Payments to redeem preferred stock issued by a subsidiary	0	0	375,000
Proceeds from issuance of preferred stock by a subsidiary	0	0	296,370
Stock repurchases	(99,997)	(100,000)	0
Dividends paid to stockholders	299,579	301,456	297,555
Dividends paid to noncontrolling interests	(18,375)	(19,141)	(19,485)
Net cash used in financing activities	(455,017)	(579,968)	(625,861)
Effect of exchange rate changes on cash and cash equivalents	(4,679)	976	9,829
(Decrease) increase in cash and cash equivalents	371,875	71,626	36,066
Cash and cash equivalents at beginning of period	484,363	412,737	376,671
Cash and cash equivalents at end of period	856,238	484,363	412,737
Cash interest paid	202,159	191,880	195,256
Cash income taxes paid, net	$ 44,528	$ 231,550	$ 197,925